|
National Stock Number(NSN): 6505-01-198-9629 (6505011989629, 011989629)
| NIIN: |
01-198-9629 |
Item Name: |
NITROGLYCERIN EXTENDED-RELEASE CAPSULES |
INC: |
42609
|
| FSC: |
6505
|
Assignment Date: |
Jan-16-1985 |
CRIT: |
X |
IIG: |
42609 |
| ISC: |
5 |
Date Standardized: |
Jan-16-1985 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Oct-22-2024 |
PMIC: |
U |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9220 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00182-0703-01 |
63488
|
GOLDLINE LABORATORIES, INC. |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC47679-0267-01 |
63998
|
BAXTER HEALTHCARE CORP PHARMACEUTICALS DIV |
H |
3 |
2 |
4 |
54 |
|
|
|
|
|
|
|
NDC49335-3010-01 |
26191
|
CORD LABORATORIES INC |
H |
3 |
1 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
ANY ACCEPTABLE |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
100.000 |
| FEAT |
SPECIAL FEATURES |
LONG ACTION METHOD:EXTENDED RELEASE; |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V540 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|